| P2093 | author name string | A Tan | |
| | H E Elphick | |
| P2860 | cites work | Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 |
| | Systematic reviews and lifelong diseases | Q34787080 |
| | Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis | Q35563227 |
| | Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group | Q38505793 |
| | Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal | Q39820716 |
| | Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis | Q40789277 |
| | Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. | Q41091925 |
| | Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin | Q41221196 |
| | An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients | Q42058123 |
| | Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment | Q42758295 |
| | Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis | Q43525951 |
| | Current understanding of the inflammatory process in cystic fibrosis: onset and etiology | Q44248066 |
| | Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? | Q44379999 |
| | Aminoglycoside induced ototoxicity in patients with cystic fibrosis | Q44858433 |
| | Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis | Q45031290 |
| | Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). | Q50564526 |
| | Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis. | Q54452683 |
| | Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo | Q54501407 |
| P433 | issue | 1 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | CD002007 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. | |